Schwartz (Drew) Lab

Delivering personalized gut microbiome-based risk assessment and antibiotic stewardship to combat pediatric sepsis our lab aims to reduce morbidity and mortality from bacterial infections in infants by improving diagnostics and treatment strategies. We study how antibiotics disrupt the gut microbiome and immune development, increasing sepsis risk. Using microbial sequencing, immune profiling and computational modeling we develop algorithms to predict sepsis risk and guide optimal antibiotic therapy for vulnerable pediatric populations.